Pfizer (PFE) announced a clean beat on the top and bottom lines this week and raised its full-year earnings forecast and the lower end of its revenue guidance. It also increased its full-year sales guidance for its COVID-19 vaccine by $2 billion to $34 billion.
Additionally, the company says it has enough promising data on its respiratory syncytial virus (RSV) vaccine for newborns to seek FDA approval by the end of the year.
Let’s sell a put to generate income and reduce our net debit on the position.
You can enter today’s trade even if you were not in the previous one. Just be aware that we will be managing and tracking it based on the ongoing position.
Current Stock Price: $46.45
Net Debit: $10.18
Current Option Price: $0.56-$0.61
Action: Sell to open the PFE Nov Week Two (11/11) 46 Put for around $0.58, but adjust as needed to sell a put today
New Net Debit: $9.60
Expiration: After the close on Friday, Nov. 11
Potential Rate of Return: I am targeting breakeven for this position